What we found on the web about Drug Candidates
Drug discovery - Wikipedia, the free encyclopedia
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed. In the past most drugs have been discovered ...
David Zarling - Wikipedia, the free encyclopedia
CPC drug candidates showed significant pre-clinical efficacy in regression of prostate cancer and prevention of metastasis. Before starting Colby Pharmaceutical Company, Dr. Zarling ...
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan ...
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA. - Phase 2 Clinical Trial in Patients with Carcinoid Syndrome Ongoing in U.S ...
Centre for Drug Candidate Optimisation
Established in 2003, the Centre for Drug Candidate Optimisation is a unique venture that provides collaborative lead candidate optimisation in support of emerging drug discovery ...
Hemispherx Biopharma, Inc. -- Research and Development: Drug ...
Ampligen® Nucleic acid compounds represent a potential new class of pharmaceutical products that are designed to act at the molecular level for treatment of human diseases.
Significant Differences Among Candidates' Drug Policies
The differences among the two presidential candidates are sharp, including that of drug policies. According to The News-Sentinel October 20, 2008 article, ("McCain Would Focus On ...
CombinatoRx-Derived Combination Drug Candidate, Prednisporin, Acquired ...
Oct 5, 2009 - CombinatoRx, Incorporated (NASDAQ CRXX), today announced that its ophthalmic collaborator, Fovea Pharmaceuticals SA, has entered into a proposed a
Syntrix Biosystems
Syntrix Biosystems is working to discover, develop and commercialize small molecule drug candidates to treat cancer, disorders of inflammation, and stimulate ...
Anti-HIV Candidates in the Pipeline - The Body
In the past year or so, the HIV drug pipeline seemed to slow to a trickle, with only one new approval, tenofovir (Viread). But the future is beginning to ...
BiPar Sciences Inc. - Press Releases
BiPar Sciences Raises $35 Million to Advance Pipeline of Novel PARP Inhibitor Cancer Drug Candidates - Series B Financing Round Led By Domain Associates; Treu,
NanoViricides, Inc. Anti-Herpes Drug Candidate Reduces Viral Load by ...
Aug 10, 2009 - NanoViricides, Inc. (OTC BB NNVC.OB) (the Company ), announced today that the herpes simplex viral load was reduced by 99.99 or 10,000 fold in in
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Drug Candidates

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Drug Candidates
OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday ...
Stockhouse
... expand the approved indications for Tarceva, OSI's ability to protect its intellectual property rights, safety concerns regarding Tarceva, competition to Tarceva and OSI's drug candidates from other biotechnology and pharmaceutical comp...
Ablynx Achieves Third Milestone in Drug Discovery and Development Collaboration
Marketwire via Yahoo! Finance
GHENT, BELGIUM--(Marketwire - 11/18/09) - GHENT, Belgium, 18 November 2009 - Ablynx [Euronext Brussels: ABLX ], announced today that it will receive an undisclosed milestone payment from Novartis. The payment has been triggered by successfu...
Biota Acquires Assets from Prolysis and MaxThera for Roughly $11.5M
Genetic Engineering News
MaxThera shareholders will also be entitled to 12% of all up-front and milestone fees received by Biota if the two main drug candidates are licensed. Commenting on the Prolysis deal, Biota CEO, Peter Cooke, says, “This acquisition will enab...
Afghan President Karzai sworn in to second term
USA Today
Afghan President Hamid Karzai promised Thursday to prosecute corrupt officials and end a culture of impunity in an inauguration speech made under intense international pressure that he shed the cronyism and graft that marked his first term.
LGBT’s come out vs. Comelec
Sun Star
If we give Ang Ladlad a chance, then we will also give chances for other groups, such as drug addicts, drunkards and pedophiles to apply as party-list candidates.” Bullecer said Ang Ladlad also cannot be considered as a marginalized sector,...
Trimeris Receives Request from Arigene for Extension of Tender Offer ...
Stockhouse
... development activities, regulatory authorizations and product commercializations; we are dependent on third parties for the sale, marketing and distribution of the Company's drug candidates; the market for HIV therapeutics is very compe...
Suspected drug lab busted
CBC Toronto
Neighbours' noses led Toronto police to a suspected drug lab in a residential neighbourhood in the city's north end overnight between Tuesday and Wednesday.
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop ...
Xconomy
... enough momentum for its stem cell production technology that it will become a useful tool for creating models of disease in the lab, and for toxicology testing to see which drug candidates have the best odds of success. Further in the f...
PPD To Acquire BioDuro
PharmaceuticalOnline
PPD, Inc. (Nasdaq: PPDI) today announced it has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company that provides a broad range of integrated services to biopharmaceutical companies. The acquisition will expand ...